Kamada (KMDA) EBIT Growth (5y) (2017 - 2026)
Kamada (KMDA) EBIT Growth (5y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Kamada | 464.34 Mn | 434.87 Mn | 22.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 55.50% |
| Mar 31, 2026 | 14.75% |
| Dec 31, 2025 | 16.77% |
| Sep 30, 2025 | 6.62% |
| Jun 30, 2025 | 415.79% |
| Mar 31, 2025 | 6.12% |
| Dec 31, 2024 | 11.95% |
| Sep 30, 2024 | 11.45% |
| Jun 30, 2024 | -2.48% |
| Mar 31, 2024 | -8.58% |
| Dec 31, 2023 | -29.00% |
| Sep 30, 2023 | 344.36% |
| Jun 30, 2023 | -12.64% |
| Mar 31, 2023 | 198.08% |
| Dec 31, 2022 | -9.02% |
| Sep 30, 2022 | 380.62% |
| Jun 30, 2022 | -19.69% |
| Mar 31, 2022 | 15.62% |
| Dec 31, 2021 | -11.76% |
| Sep 30, 2021 | 25.85% |